Blood-based biomarkers of cerebral small vessel disease
Top Cited Papers
Open Access
- 26 February 2024
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 95, 102247
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (2019100)
- National Medical Research Council (MOH-000500-03)
- National Medical Research Council (MOH-000707-01)
- National Medical Research Council (MOH-001086-00)
This publication has 256 references indexed in Scilit:
- Placental growth factor as a sensitive biomarker for vascular cognitive impairmentAlzheimer's & Dementia, 2023
- Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular diseaseAlzheimer's & Dementia, 2021
- MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocolsAlzheimer's & Dementia, 2021
- Cognitive impairment in sporadic cerebral small vessel disease: A systematic review and meta‐analysisAlzheimer's & Dementia, 2020
- Relation of plasma β‐amyloid, clusterin, and tau with cerebral microbleeds: Framingham Heart StudyAnnals of Clinical and Translational Neurology, 2020
- Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related EndophenotypesJAMA Neurology, 2019
- Ergothioneine – a diet‐derived antioxidant with therapeutic potentialFEBS Letters, 2018
- Association Between Subclinical Cardiac Biomarkers and Clinically Manifest Cardiac Diseases With Cortical Cerebral MicroinfarctsJAMA Neurology, 2017
- Association of Vitamin B12, Folate, and Sulfur Amino Acids With Brain Magnetic Resonance Imaging Measures in Older AdultsJAMA Psychiatry, 2016
- Emerging Noninvasive Biochemical Measures to Predict Cardiovascular RiskArchives of internal medicine (1960), 1999